JP2011500717A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500717A5 JP2011500717A5 JP2010530121A JP2010530121A JP2011500717A5 JP 2011500717 A5 JP2011500717 A5 JP 2011500717A5 JP 2010530121 A JP2010530121 A JP 2010530121A JP 2010530121 A JP2010530121 A JP 2010530121A JP 2011500717 A5 JP2011500717 A5 JP 2011500717A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- compound
- cancer
- salt
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 13
- 150000003839 salts Chemical class 0.000 claims 7
- 239000011780 sodium chloride Substances 0.000 claims 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims 6
- 241000124008 Mammalia Species 0.000 claims 4
- 238000007920 subcutaneous administration Methods 0.000 claims 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 4
- 201000011510 cancer Diseases 0.000 claims 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims 2
- 229940035504 Tromethamine Drugs 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 229960000281 trometamol Drugs 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 206010017758 Gastric cancer Diseases 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010025650 Malignant melanoma Diseases 0.000 claims 1
- 208000008443 Pancreatic Carcinoma Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 239000002246 antineoplastic agent Substances 0.000 claims 1
- 201000011231 colorectal cancer Diseases 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 201000001441 melanoma Diseases 0.000 claims 1
- 201000002528 pancreatic cancer Diseases 0.000 claims 1
- 201000011549 stomach cancer Diseases 0.000 claims 1
Claims (14)
- 前記pHが約8.2から9.3の間であることを特徴とする請求項1に記載の組成物。
- 前記pHが約8.5から9.0の間であることを特徴とする請求項1に記載の組成物。
- 前記分子式Iの化合物又は該化合物の塩の濃度が約30mg/mL以上であることを特徴とする請求項1乃至3のいずれか1項に記載の組成物。
- 前記分子式Iの化合物又は該化合物の塩の濃度が約120mg/mLであることを特徴とする請求項1乃至3のいずれか1項に記載の組成物。
- 前記組成物が、哺乳動物において、癌、血栓塞栓性疾患、または癌および血栓塞栓性疾患を治療する際に使用されることを特徴とする請求項1乃至5のいずれか1項に記載の組成物。
- 前記癌が、前立腺癌、膵臓癌、胃癌、乳癌、結腸直腸癌、肺癌、及びメラノーマから選択されることを特徴とする請求項6に記載の組成物。
- 哺乳動物に皮下投与するのに適した形態の組成物であって、該皮下投与は、注射器を用いて行われ、および注射器の針のゲージ数が約20から約30の間であることを特徴とする請求項1乃至7のいずれか1項に記載の組成物。
- 前記分子式Iの化合物又は該化合物の塩を含む組成物に加えて化学療法剤をさらに含むことを特徴とする請求項1乃至8のいずれか1項に記載の組成物。
- 前記注射器の針のゲージ数が約20から約30の間であり、および前記分子式Iの化合物又は該化合物の塩の濃度が約30mg/mL以上であることを特徴とする請求項10に記載の機器。
- 前記注射器の針のゲージ数が約20から約30の間であり、および前記分子式Iの化合物又は該化合物の塩の濃度が約120mg/mLであることを特徴とする請求項10に記載の機器。
- 前記pHが約8.2から9.3の間であることを特徴とする請求項10乃至12のいずれか1項に記載の機器。
- 前記pHが約8.5から9.0の間であることを特徴とする請求項10乃至12のいずれか1項に記載の機器。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US98038607P | 2007-10-16 | 2007-10-16 | |
US60/980,386 | 2007-10-16 | ||
PCT/US2008/080221 WO2009052323A2 (en) | 2007-10-16 | 2008-10-16 | Manufacture, compositions and uses of coagulationfactor viia modulator |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015078702A Division JP2015157830A (ja) | 2007-10-16 | 2015-04-07 | 凝血因子VIIaモジュレーターの製造、組成物及び使用 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2011500717A JP2011500717A (ja) | 2011-01-06 |
JP2011500717A5 true JP2011500717A5 (ja) | 2011-11-17 |
JP5733744B2 JP5733744B2 (ja) | 2015-06-10 |
Family
ID=40568072
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010530121A Active JP5733744B2 (ja) | 2007-10-16 | 2008-10-16 | 凝血因子VIIaモジュレーターの製造、組成物及び使用 |
JP2015078702A Pending JP2015157830A (ja) | 2007-10-16 | 2015-04-07 | 凝血因子VIIaモジュレーターの製造、組成物及び使用 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2015078702A Pending JP2015157830A (ja) | 2007-10-16 | 2015-04-07 | 凝血因子VIIaモジュレーターの製造、組成物及び使用 |
Country Status (10)
Country | Link |
---|---|
US (3) | US8552046B2 (ja) |
EP (2) | EP2586794A3 (ja) |
JP (2) | JP5733744B2 (ja) |
KR (1) | KR20100093046A (ja) |
CN (2) | CN101861335B (ja) |
CA (1) | CA2702970A1 (ja) |
EA (2) | EA019258B1 (ja) |
ES (1) | ES2403413T3 (ja) |
HK (1) | HK1147267A1 (ja) |
WO (1) | WO2009052323A2 (ja) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7479502B2 (en) | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
NZ551728A (en) | 2004-06-02 | 2010-03-26 | Pharmacyclics Inc | Factor VIIa inhibitor |
US8729117B2 (en) | 2004-06-02 | 2014-05-20 | Pharmacyclics, Inc. | Factor VIIa inhibitor |
US8552046B2 (en) | 2007-10-16 | 2013-10-08 | Pharmacyclics, Inc. | Manufacture, compositions and uses of coagulation factor VIIa modulator |
WO2012142317A1 (en) * | 2011-04-15 | 2012-10-18 | Gamma Therapeutics, Inc | Fast-clotting wound dressings |
US8980823B2 (en) | 2012-03-07 | 2015-03-17 | Shaker A. Mousa | Formulations of Factor VIIa inhibitors and utility |
PE20150226A1 (es) | 2012-04-16 | 2015-02-14 | Cantab Biopharmaceuticals Patent Ltd | Agentes terapeuticos para administracion subcutanea optimizados |
EP3016646A4 (en) * | 2013-07-05 | 2017-03-01 | Shaker A. Mousa | NOVEL FORMULATIONS OF FACTOR VIIa INHIBITORS AND UTILITY |
ES2959451T3 (es) | 2013-09-11 | 2024-02-26 | Eagle Biologics Inc | Formulaciones proteicas líquidas que contienen organofosfatos |
KR102497368B1 (ko) * | 2014-10-01 | 2023-02-10 | 이글 바이올로직스 인코포레이티드 | 점도-저하제를 함유하는 폴리삭카라이드 및 핵산 제형 |
RU2641058C1 (ru) * | 2016-11-17 | 2018-01-15 | федеральное государственное автономное образовательное учреждение высшего образования "Российский университет дружбы народов" (РУДН) | Способ профилактики венозной тромбоэмболии у больных раком шейки матки |
CN109627218B (zh) * | 2018-11-27 | 2022-03-29 | 深圳市龙华区中心医院 | 一种抗凝小分子化合物及其应用和包含其的药物 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5033252A (en) | 1987-12-23 | 1991-07-23 | Entravision, Inc. | Method of packaging and sterilizing a pharmaceutical product |
US5052558A (en) | 1987-12-23 | 1991-10-01 | Entravision, Inc. | Packaged pharmaceutical product |
US5323907A (en) | 1992-06-23 | 1994-06-28 | Multi-Comp, Inc. | Child resistant package assembly for dispensing pharmaceutical medications |
RU2093176C1 (ru) * | 1992-12-16 | 1997-10-20 | Левон Никитович Мкртчян | Способ лечения рака молочной железы и рака тела матки |
CZ20012006A3 (cs) * | 1998-12-18 | 2002-03-13 | Axys Pharmaceuticals, Inc. | Sloučenina a farmaceutický prostředek |
US6465503B2 (en) | 2000-08-11 | 2002-10-15 | Axys Pharmaceuticals, Inc. | Selective urokinase inhibitors |
US20020037912A1 (en) | 2000-08-11 | 2002-03-28 | Leahy Ellen M. | Factor viia inhibitors |
RU2288746C2 (ru) * | 2001-03-23 | 2006-12-10 | Ново Нордиск А/С | Игольчатая канюля, способ изготовления игольчатой канюли и использование игольчатой канюли |
EP1408963A1 (en) | 2001-07-09 | 2004-04-21 | Axys Pharmaceuticals, Inc. | 2- 5-(5-CARBAMIMIDOYL-1 i H /i -HETEROARYL)-6-HYDROXYBIPHENYL-3-YL]-SUCCINIC ACID DERIVATIVES AS FACTOR VIIA INHIBITORS |
KR20040065278A (ko) * | 2001-12-21 | 2004-07-21 | 노보 노르디스크 에이/에스 | 변경된 인자 ⅶ 폴리펩티드의 액체 조성물 |
JP2005523279A (ja) * | 2002-02-13 | 2005-08-04 | アクシス ファーマシューティカルズ インコーポレイティッド | 第viia因子阻害剤としての2−[5−(5−カルバミミドイル−1h−ヘテロアリール)]−6−ヒドロキシビフェニル−3−イル誘導体 |
WO2003086413A1 (en) * | 2002-04-08 | 2003-10-23 | Guilford Pharmaceuticals, Inc. | Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same |
US7479502B2 (en) * | 2002-12-03 | 2009-01-20 | Pharmacyclics, Inc. | 2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors |
AU2003300106A1 (en) * | 2003-01-08 | 2004-08-10 | Axys Pharmaceuticals, Inc. | 2-'5-(5-carbamimidoyl-1h-heteroaryl)-6-hydroxybiphenyl-3-yl!- carboxylic acid derivatives as factor viia inhibitors |
NZ551728A (en) * | 2004-06-02 | 2010-03-26 | Pharmacyclics Inc | Factor VIIa inhibitor |
CN1976903A (zh) * | 2004-06-02 | 2007-06-06 | 法莫西克立克斯公司 | 因子VⅡa抑制剂 |
US8552046B2 (en) | 2007-10-16 | 2013-10-08 | Pharmacyclics, Inc. | Manufacture, compositions and uses of coagulation factor VIIa modulator |
US20110299806A1 (en) * | 2010-06-08 | 2011-12-08 | Leonid Kashchenevsky | Spindle, shaft supporting device and method of supporting a rotatable shaft |
-
2008
- 2008-10-16 US US12/738,372 patent/US8552046B2/en active Active
- 2008-10-16 CA CA2702970A patent/CA2702970A1/en not_active Abandoned
- 2008-10-16 CN CN2008801165837A patent/CN101861335B/zh active Active
- 2008-10-16 WO PCT/US2008/080221 patent/WO2009052323A2/en active Application Filing
- 2008-10-16 EP EP12185553.0A patent/EP2586794A3/en not_active Withdrawn
- 2008-10-16 EA EA201000633A patent/EA019258B1/ru unknown
- 2008-10-16 EA EA201370191A patent/EA201370191A1/ru unknown
- 2008-10-16 KR KR1020107010696A patent/KR20100093046A/ko not_active Application Discontinuation
- 2008-10-16 EP EP08839610A patent/EP2209801B1/en active Active
- 2008-10-16 JP JP2010530121A patent/JP5733744B2/ja active Active
- 2008-10-16 ES ES08839610T patent/ES2403413T3/es active Active
- 2008-10-16 CN CN201310334580.3A patent/CN103705507A/zh active Pending
-
2011
- 2011-02-15 HK HK11101423.2A patent/HK1147267A1/xx unknown
-
2012
- 2012-11-02 US US13/668,167 patent/US8748468B2/en active Active
-
2013
- 2013-10-08 US US14/049,143 patent/US20140039022A1/en not_active Abandoned
-
2015
- 2015-04-07 JP JP2015078702A patent/JP2015157830A/ja active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2011500717A5 (ja) | ||
JP2010528026A5 (ja) | ||
JP2008528671A5 (ja) | ||
RU2012118974A (ru) | Комбинации ингибитора pi3k и ингибитора мек | |
HRP20160014T1 (hr) | Derivati 1-((5-heteroariltiazol-2-il)aminokarbonil)pirolidin-2-karboksamida kao inhibitori fosfatidilinozitol 3-kinaze (pi3k), koji su korisni u lijeäśenju proliferativnih bolesti | |
US20120322820A1 (en) | Methods to inhibit tumor cell growth by using proton pump inhibitors | |
JP2020514311A5 (ja) | ||
RU2007119432A (ru) | Способ лечения рака | |
JP2016006096A5 (ja) | ||
RU2015106524A (ru) | ФАРМАЦЕВТИЧЕСКИЕ КОМБИНАЦИИ ИНГИБИТОРА CDK4/6 И ИНГИБИТОРА В-Raf | |
JP2009536191A5 (ja) | ||
JP2020097577A5 (ja) | ||
JP2014513136A5 (ja) | ||
JP2009513662A5 (ja) | ||
JP2017526662A5 (ja) | ||
JP2011518202A5 (ja) | ||
JP2015512413A5 (ja) | ||
JP2016529285A5 (ja) | ||
WO2012117257A8 (en) | Diethylstilbestrol dosage form and use for the treatment of prostate or breast cancer | |
JP2019511550A5 (ja) | ||
JP2016527202A5 (ja) | ||
US20190374649A1 (en) | Inhibitors of nhe-mediated antiport | |
CN103265560A (zh) | 棉酚/棉酮衍生物及其制备方法和抗肿瘤药物中的应用 | |
JP2014512355A5 (ja) | ||
RU2014118490A (ru) | Лечение фармакологически индуцированной гипохлоргидрии |